Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Beijing InnoCare Pharma Tech Co., Ltd.
Study ID
NCT07236099
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Prurigo Nodularis (PN)

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • ICP-322 — DRUG
    ICP-322 Tablets
  • Placebo — DRUG
    ICP-332 Placebo Tablets

Study Details

Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)

Key Dates

First listed
Nov 19, 2025
Start date
Nov 27, 2025
Status verified
Dec 2025
Primary completion
Mar 31, 2027
Completion
Oct 31, 2027

Study Design

Enrollment
135 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: ICP-332 80mg
  • Experimental: ICP-332 120mg
  • Placebo Comparator: Placebo

Primary Outcome Measure

Peak pruritus-numeric rate scale (PP NRS) [ Time Frame: Baseline to week 16 ]

Central Contacts

Locations (10)

FacilityCityStateZIPSite coordinators
Cahaba Dermatology and Skin Health CenterBirminghamAlabama35244
Vlada Groysman
Medical Dermatology SpecialistsPhoenixArizona85006
Lindsay Ackerman
Driven Research, LLCCoral GablesFlorida33134
Javier Alonso-Llamazares
Cordova Research InstituteSweetwaterFlorida33182
Maria Cartaya
Dawes Fretzin Clinical Research Group LLCIndianapolisIndiana46250
Kenneth W. Dawes
The Derm Institute of West MichiganCaledoniaMichigan49316
Kristi Hawley
Revival Research Institute, LLCTroyMichigan48084
Ali Moiin
Minnesota Clinical Study CenterNew BrightonMinnesota55112
Steven Kempers
Skin Specialists, PCOmahaNebraska68144
Joel Schlessinger
Apex Clinical Research CenterMayfield HeightsOhio44124
Jorge A Garcia-Zuazaga

Find similar trials in Birmingham, AL

By research site
Cahaba Dermatology and Skin Health Center· Birmingham, ALMedical Dermatology Specialists· Phoenix, AZDriven Research, LLC· Coral Gables, FLCordova Research Institute· Sweetwater, FLDawes Fretzin Clinical Research Group LLC· Indianapolis, INThe Derm Institute of West Michigan· Caledonia, MI

Related Studies